ホーム › 膵臓がん › カリフォルニア州

カリフォルニア州における膵臓がんの臨床試験

カリフォルニア州内の拠点で、膵臓がんに関する91件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト（英語）

The Vanguard Study: Testing a New Way to Screen for Cancer

Kaiser Permanente-Division of Research, Pleasanton

被験者募集中健康なボランティア歓迎

45歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06995898

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, Los Angeles
Research Site, San Francisco

被験者募集中第1/2相

18歳〜130歳 · 全性別 · 2026/10/05更新 · NCT05417594

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

City of Hope, Duarte
University of California San Diego, San Diego

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/05更新 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
他2件

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

City of Hope Duarte, Duarte
University of California at Los Angeles, Santa Monica

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT07529808

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
他10件

被験者募集中

18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
Ronald Reagan UCLA Medical Center, Los Angeles
他3件

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Los Angeles
PHN-012-001 Site, San Diego

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Duarte, Duarte
Providence Medical Foundation, Santa Rosa

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413

Pancreatic Cancer Detection Consortium

City of Hope Medical Center, Monrovia

被験者募集中観察研究健康なボランティア歓迎

18歳以上 · 全性別 · 2026/09/28更新 · NCT06388967

DESTINY-PANTUMOUR04

Research Site, San Diego

被験者募集中観察研究

18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

UC San Diego Medical Center - Encinitas, Encinitas
Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UCI Health - Irvine, Irvine
他14件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/24更新 · NCT07229313

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

UC San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles, Los Angeles
他3件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Investigative Site US051, Duarte
Investigative Site US085, Fullerton
Investigative Site US054, La Jolla
他7件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton, Fullerton
UCI Health - Irvine, Irvine
Cedars-Sinai - Cedars-Sinai Medical Center, Los Angeles
他2件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272

UCSF PANC Cyst Registry

University of California, San Francisco, San Francisco

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/22更新 · NCT04291651

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

UC San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
UCLA Hematology/Oncology- Santa Monica, Los Angeles

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

University of California, San Francisco, San Francisco

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/21更新 · NCT06271291

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0096, San Francisco

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680

CREO - Microwave Ablation Feasibility Study

Cedars Sinai, Los Angeles

被験者募集中

18歳以上 · 全性別 · 2026/09/14更新 · NCT07817147

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Children's Hospital Los Angeles, Los Angeles
Cedars Sinai Medical Center, Los Angeles
UCSF Benioff Children's Hospital Oakland, Oakland
他1件

被験者募集中観察研究

17歳以下 · 全性別 · 2026/09/11更新 · NCT06651580

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

City of Hope, Duarte

被験者募集中

18歳以上 · 全性別 · 2026/09/10更新 · NCT05764720

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

USC/Norris Comprehensive Cancer Center, Los Angeles

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/09更新 · NCT06440005

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
UC San Diego Moores Cancer Center, La Jolla
Loma Linda University Medical Center, Loma Linda
他5件

被験者募集中観察研究

50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

START- Los Angeles, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Valkyrie Clinical Trials, Los Angeles

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/03更新 · NCT07644559

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/03更新 · NCT05687123

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Hoag Memorial Hospital Presbyterian, Newport Beach

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/02更新 · NCT06673017

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
他2件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/01更新 · NCT04172532